Cargando…
Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways
OBJECTIVE: Liver fibrosis is a consequence of wound-healing responses to chronic liver insult and may progress to liver cirrhosis if not controlled. This study investigated the protection against liver fibrosis by isorhamnetin. METHODS: Mouse models of hepatic fibrosis were established by intraperit...
Autores principales: | Liu, Ning, Feng, Jiao, Lu, Xiya, Yao, Zhilu, Liu, Qing, Lv, Yang, Han, Yuru, Deng, Jingfan, Zhou, Yingqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701280/ https://www.ncbi.nlm.nih.gov/pubmed/31467486 http://dx.doi.org/10.1155/2019/6175091 |
Ejemplares similares
-
Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways
por: Wu, Liwei, et al.
Publicado: (2017) -
Rejuvenation by inhibiting TGF-β1/pSmad signaling
por: Corder, Elizabeth H., et al.
Publicado: (2015) -
Protective effect of fucoidan from Fucus vesiculosus on liver fibrosis via the TGF-β1/Smad pathway-mediated inhibition of extracellular matrix and autophagy
por: Li, Jingjing, et al.
Publicado: (2016) -
TGF-β-induced growth inhibition in B-cell lymphoma correlates with Smad1/5 signalling and constitutively active p38 MAPK
por: Bakkebø, Maren, et al.
Publicado: (2010) -
Celastrol inhibits colorectal cancer through TGF-β1/Smad signaling
por: Jiang, Zhitao, et al.
Publicado: (2019)